Bayer AG (BAYRY)
10.16
-0.03
(-0.29%)
USD |
OTCM |
Jun 10, 16:00
Bayer Debt to Equity Ratio : 1.348 for March 31, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| March 31, 2026 | 1.348 |
| December 31, 2025 | 1.443 |
| September 30, 2025 | 1.340 |
| June 30, 2025 | 1.265 |
| March 31, 2025 | 1.214 |
| December 31, 2024 | 1.277 |
| September 30, 2024 | 1.347 |
| June 30, 2024 | 1.305 |
| March 31, 2024 | 1.300 |
| December 31, 2023 | 1.360 |
| September 30, 2023 | 1.421 |
| June 30, 2023 | 1.259 |
| March 31, 2023 | 1.060 |
| December 31, 2022 | 1.069 |
| September 30, 2022 | 1.085 |
| June 30, 2022 | 1.174 |
| March 31, 2022 | 1.136 |
| December 31, 2021 | 1.236 |
| September 30, 2021 | 1.343 |
| June 30, 2021 | 1.329 |
| March 31, 2021 | 1.239 |
| December 31, 2020 | 1.364 |
| September 30, 2020 | 1.387 |
| June 30, 2020 | 1.157 |
| March 31, 2020 | 0.8231 |
| Date | Value |
|---|---|
| December 31, 2019 | 0.8247 |
| September 30, 2019 | 0.9543 |
| June 30, 2019 | 0.9695 |
| March 31, 2019 | 0.881 |
| December 31, 2018 | 0.8966 |
| September 30, 2018 | 0.8731 |
| June 30, 2018 | 1.106 |
| March 31, 2018 | 0.3662 |
| December 31, 2017 | 0.3732 |
| September 30, 2017 | 0.4333 |
| June 30, 2017 | 0.5882 |
| March 31, 2017 | 0.5648 |
| December 31, 2016 | 0.6236 |
| September 30, 2016 | 0.822 |
| June 30, 2016 | 0.8675 |
| March 31, 2016 | 0.8597 |
| December 31, 2015 | 0.79 |
| September 30, 2015 | 1.013 |
| June 30, 2015 | 1.112 |
| March 31, 2015 | 1.077 |
| December 31, 2014 | 1.055 |
| September 30, 2014 | 0.7187 |
| June 30, 2014 | 0.5963 |
| March 31, 2014 | 0.5828 |
| December 31, 2013 | 0.4209 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| SenesTech, Inc. | 0.3414 |
| Dermapharm Holding SE | 1.407 |
| Johnson & Johnson | 0.6773 |
| Pfizer Inc. | 0.7154 |
| AstraZeneca PLC | 0.7166 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 124.37B |
| Total Liabilities (Quarterly) | 91.00B |
| Shareholders Equity (Quarterly) | 33.24B |
| Current Ratio | 1.055 |
| Net Debt Paydown Yield | -1.16% |